GABA and Glutamate Receptors as Therapeutic Targets in Neurodegenerative Disorders
- 1 February 1992
- journal article
- review article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 70 (2) , 95-104
- https://doi.org/10.1111/j.1600-0773.1992.tb00436.x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Neurotoxic Action of Kainic Acid in the Developing Rat StriatumPublished by S. Karger AG ,2015
- Analogues of the low-efficacy partial GABAA agonist 4-PIOL. Syntheses and in vitro pharmacological studiesEuropean Journal of Medicinal Chemistry, 1991
- Novel Glutamate Receptor Antagonists Selectively Protect Against Kainic Acid Neurotoxicity in Cultured Cerebral Cortex NeuronsJournal of Neurochemistry, 1990
- Treatment of Alzheimer's DiseaseThe British Journal of Psychiatry, 1990
- Muscimol injections in the medial septum impair spatial learningBrain Research, 1990
- GABA-A agonists and GABA uptake inhibitors: Structure-activity relationshipsDrug Development Research, 1990
- Involvement of the amygdala GABAergic system in the modulation of memory storageBrain Research, 1989
- A “Glutamatergic Hypothesis” of SchizophreniaClinical Neuropharmacology, 1989
- GABA-Mimetic Activity and Effects on Diazepam Binding of Aminosulphonic Acids Structurally Related to Piperidine-4-Sulphonic AcidJournal of Neurochemistry, 1985
- THIP treatment of Huntington's diseaseNeurology, 1983